cholestyramine resin has been researched along with theophylline in 2 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (theophylline) | Trials (theophylline) | Recent Studies (post-2010) (theophylline) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 20,076 | 1,612 | 1,383 |
| Protein | Taxonomy | cholestyramine resin (IC50) | theophylline (IC50) |
|---|---|---|---|
| Adenosine receptor A1 | Bos taurus (cattle) | 2.43 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| al-Shareef, AH; Allen, EM; Buss, DC; Routledge, PA | 1 |
| Fears, R; Ferres, H; Haacke, H; Mäder, C; Parwaresch, MR | 1 |
1 trial(s) available for cholestyramine resin and theophylline
| Article | Year |
|---|---|
Decrease in LDL and increase in HDL concentrations in type II hyperlipoproteinaemic patients on low-dose combination therapy of cholestyramine and Complamin.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cholestyramine Resin; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Lipoproteins, VLDL; Male; Middle Aged; Theophylline; Xanthinol Niacinate | 1988 |
1 other study(ies) available for cholestyramine resin and theophylline
| Article | Year |
|---|---|
The effects of charcoal and sorbitol (alone and in combination) on plasma theophylline concentrations after a sustained-release formulation.
Topics: Adult; Aminophylline; Biological Availability; Charcoal; Cholestyramine Resin; Colestipol; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Sorbitol; Theophylline; Time Factors | 1990 |